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Original Article
Development and Characterization of Acellular Porcine
Pulmonary Valve Scaffolds for Tissue Engineering
Ji Luo, PhD,1 Sotirios A. Korossis, PhD,2 Stacy-Paul Wilshaw, PhD,1 Louise M Jennings, PhD,1
John Fisher, PhD,1 and Eileen Ingham, PhD1
Currently available replacement heart valves all have limitations. This study aimed to produce and characterize
an acellular, biocompatible porcine pulmonary root conduit for reconstruction of the right ventricular outflow
tract e.g., during Ross procedure. A process for the decellularization of porcine pulmonary roots was developed
incorporating trypsin treatment of the adventitial surface of the scraped pulmonary artery and sequential
treatment with hypotonic Tris buffer (HTB; 10mM Tris pH 8.0, 0.1% (w/v) EDTA, and 10 KIU aprotinin),
0.1% (w/v) sodium dodecyl sulfate in HTB, two cycles of DNase and RNase, and sterilization with 0.1% (v/v)
peracetic acid. Histology confirmed an absence of cells and retention of the gross histoarchitecture. Im-
munohistochemistry further confirmed cell removal and partial retention of the extracellular matrix, but a loss
of collagen type IV. DNA levels were reduced by more than 96% throughout all regions of the acellular tissue
and no functional genes were detected using polymerase chain reaction. Total collagen levels were retained but
there was a significant loss of glycosaminoglycans following decellularization. The biomechanical, hydrody-
namic, and leaflet kinematics properties were minimally affected by the process. Both immunohistochemical
labeling and antibody absorption assay confirmed a lack of a-gal epitopes in the acellular porcine pulmonary
roots and in vitro biocompatibility studies indicated that acellular leaflets and pulmonary arteries were not
cytotoxic. Overall the acellular porcine pulmonary roots have excellent potential for development of a tissue
substitute for right ventricular outflow tract reconstruction e.g., during the Ross procedure.
Introduction
Heart valve dysfunction has a global prevalence,and the aortic valve is the one that is most often re-
placed. Replacement valves may be mechanical, biopros-
thetic, cryopreserved homografts, or autografts. All valve
replacements have their own advantages and disadvantages,
and none of them is ideal. Acellular natural tissue cardiac
valves offer an opportunity to create ‘‘ideal replacement
valves,’’ with the potential to overcome the limitations of
currently available replacements, including risk of throm-
boembolism, requirement for life-time anticoagulation
therapy, poor durability and abnormal hydrodyamics. For
the pediatric population, acellular heart valves may offer the
optimal solution since they should have the potential to
grow, repair, and remodel.1–3
The Ross procedure is used to treat severe aortic valve
disease in young patients. The patient’s own pulmonary
valve is used to replace the diseased aortic valve.4 Pul-
monary homografts are considered the gold standard for
right ventricular outflow tract (RVOT) reconstruction e.g.,
during the Ross procedure.5,6 The general outcome is good
with a high survival and low reoperation rate. However,
there are risk factors7,8 and the pulmonary homografts will
eventually suffer from stenosis and deterioration over time.9
The use of acellular natural valves in the pulmonary position
is therefore currently of major interest.
Different methods have been utilized to generate acellular
pulmonary valve conduits including the use of detergents
such as 0.1% (w/v) sodium dodecyl sulfate (SDS)10,11 and
Triton X-100,12 0.1% (w/v) deoxycholic acid,6 and enzymes
such as trypsin13 and nuclease.14 Currently, acellular pulmo-
nary homograft valves are used clinically. Da Costa et al.10
demonstrated that pulmonary homografts decellularized using
0.1% (w/v) SDS had low gradients over a 24 months follow-
up with an absence of any immunological reaction without
elevation of antibodies to donor MHC Class I and II. The
SynerGraft pulmonary homograft (Cryolife, Inc.), which
was treated by a proprietary process designed to substantially
reduce leaflet and conduit cellularity, is available commer-
cially, and early results have showed that it was as competent
as cryopreserved homografts.15 However, there are, as yet, no
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apparent clinical advantages to the use of the SynerGraft
pulmonary homograft over cryopreserved homografts. The
real test will be the comparative performance at 8–12 years,
when the cryopreserved homografts begin to suffer calcifica-
tion and degeneration. It is important to recognize, however,
that if acellular pulmonary homografts show advantages over
cryopreserved homografts in the longer term, there will still be
limitations in terms of the availability of human donor tissue,
especially for pediatric applications.
CryoLife applied the SynerGraft process to porcine
pulmonary valves. These valves however, failed catastroph-
ically in children due to severe inflammatory reactions most
likely caused by incomplete decellularization with residual
xenogeneic cells.16 Other acellular pulmonary xenografts that
have been used clinically include the Matrix P and Matrix
P Plus porcine pulmonary valve (AutoTissue). The Matrix
P porcine pulmonary valve (AutoTissue) comprised an acel-
lular porcine pulmonary valve supported by a glutaraldehyde-
fixed equine pericardial patch.17 Konertz et al.18 reported on
the intermediate-term clinical performance of Matrix P
(n= 9) and Matrix P Plus (n= 52) implantation. The grafts
were favorable compared to other currently available im-
plants. A number of other studies later reported inflammatory
responses to the Matrix P porcine pulmonary grafts asso-
ciated with peripheral conduit narrowing.17,19 It was also
reported that the Matrix P Plus valve displayed early
obstruction following implantation in pediatric patients.20
It is likely that these problems were due to the glutaral-
dehyde fixed pericardial patches used in the grafts.20 The
latest version of the valve, the Matrix P Plus N, has been
decribed as a cell-free valve incorporating a cell free
unfixed pericardial patch.
The evidence indicates that it is therefore of paramount
importance that any future acellular porcine pulmonary
valves developed for clinical use are devoid of cells, re-
sidual a-gal and DNA. This study presents the development
of a process to produce acellular porcine pulmonary valve
conduits, which eliminates a-gal and effectively removes
cells and DNA from all regions while retaining the biome-
chanical and pulsatile flow properties of the conduit.
Materials and Methods
Tissue procurement
Porcine hearts from Large White pigs (24 to 26 weeks
old) were obtained from a local abattoir within 4 h of
slaughter. The pulmonary heart valve together with pul-
monary artery and a myocardium skirt (from the right
ventricle) were separated from the heart. Excess fat and
connective tissue were removed and the adventitial surface
of the pulmonary artery was scraped using a scalpel blade
prior to washing in phosphate-buffered saline (PBS; Oxoid).
The porcine pulmonary roots were either used fresh, or
wiped dry and wrapped in PBS-moistened filter paper in a
sealed container and stored at - 20C as the first step of
decellularization process.
Decellularization
The decellularization process was modified from Wilcox
et al.21 for porcine aortic roots. Pulmonary roots were de-
frosted at 37C for 30min and disinfected with antibiotics
(100U.mL - 1 penicillin [Invitrogen], 100mg.mL - 1 strepto-
mycin [Invitrogen], and 50mg.mL - 1 gentamicin [Sigma-
Aldrich] in PBS) for 16–17 h at 4C. The leaflets were
masked using cotton wool soaked with 50% (v/v) fetal bo-
vine serum (FBS; Biosera) in PBS prior to trypsin treatment,
which involved brushing trypsin treatment paste
(1.125 · 104 U.mL - 1 trypsin [Sigma-Aldrich] in 0.5% (w/v)
agarose [Invitrogen] in PBS) on the adventitial surface of
the artery and myocardium skirt and incubating at 37C for
4 h. The tissue was rinsed in trypsin inhibitor solution
(trypsin inhibitor [Sigma-Aldrich] 675U.mL - 1, 0.1% [v/v]
EDTA [VWR International], and 10 KIU aprotinin [Mayfair
House] in PBS) thrice for 30min at 37C. The roots were
then sequentially washed in hypotonic Tris buffer (HTB;
10mM Tris [Sigma-Aldrich] 0.1% [v/v] EDTA, and 10 KIU
aprotinin, pH 8.0) at 40–45C for 24 h; 0.1% (v/v) SDS
(Sigma-Aldrich) in HTB at 40–45C for 24 h; nuclease
(50U.mL - 1 DNase [Sigma-Aldrich], 1U.mL - 1 RNase
[Sigma-Aldrich], 50mM Tris pH 7.5, and 10mM magne-
sium chloride [Thermo Fisher Scientific Ltd.]) at 37C for
3 h twice; hypertonic buffer (1.5M sodium chloride [Ther-
mo Fisher Scientific Ltd.] and 50mM Tris, pH 7.5) for 24 h
at 40–45C and decontaminated in 0.1% (v/v) peracetic acid
(Sigma; pH 6.0) in PBS for 3 h at 37C. Final washes in PBS
were carried out aseptically and included three 30min wa-
shes at 40–45C, three 24 h washes at 4C, and a 66 h wash
at 4C.
Histology
Fresh and decellularized specimens (n = 6) were fixed in
10% (v/v) neutral buffered formalin (NBF) for 24 h, dehy-
drated, and embedded in paraffin wax. Serial sections
(10 mm) were stained with hematoxylin and eosin (H&E),
picrosirius red/Millers elastin (to visualize collagen and
elastin), Masson’s trichrome (collagen and muscle), and
Alcian blue (glycosaminoglycans, GAGs) using standard
histological methods. Cell nuclei were visualized using
Hoechst dye (Sigma-Aldrich). Images were captured using
an upright Olympus BX51 light microscope, incorporating
an Olympus XC50 digital camera, which was controlled by
the Cell B software (Olympus).
Immunohistochemistry
Fresh and decellularized tissue specimens (n = 6) were
fixed in 10% (v/v) NBF or zinc fixative for 24 h. Monoclonal
antibodies against vimentin (Novacastra), von Willebrand
factor (vWF; DAKO), fibronectin (DAKO), and collagen IV
(DAKO) were used. Immunolabeling was carried out using
an Ultravision detection system (Thermo Scientific). Anti-
gen retrieval was employed using trypsin (for fibronectin) or
citric acid (for vWF, vimentin, collagen IV). Hydrogen
peroxide (Sigma) was used to block endogenous peroxidase.
Fresh porcine skin was used as a positive control, whereas
isotype control antibodies (IgG1 and IgG2a, both from
DAKO) and omission of the primary antibody served as
negative controls. Images were captured as described above.
Transmission electron microscopy (TEM)
Fresh and decellularized leaflet specimens (n= 2) were
fixed and embedded as described by Mirsadraee et al.22
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Sections were examined using a Jeol JEM 1400 transmis-
sion electron microscope and images were photographed.
DNA extraction
Total DNA was extracted from fresh and decellularized
tissues (n= 6) using a DNeasy blood and tissue kit from
Qiagen. Four regions of the pulmonary roots were assayed for
total DNA content: leaflet, pulmonary artery, myocardium,
and leaflet connection. Finely macerated tissue (*5 to 20mg
dry weight fresh tissue or *11 to 35mg dry weight decel-
lularized tissue) was digested using proteinase K at 56C for
16 h. RNAse was used to remove any RNA present within the
samples. The samples were washed by centrifugation to re-
move contaminating matter. Finally, the DNA was eluted into
Eppendorf tubes and quantified using a NanoDrop spectro-
photometer at 260 nm (Thermo Fisher Scientific)
Polymerase chain reaction
The presence of genes for glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), swine leukocyte antigen 2 (SLA-
2), b 2-microglobulin, and b-actin in DNA extracted from
the fresh and decellularized porcine pulmonary root tissue
samples was assessed by polymerase chain reaction (PCR).
Primers were custom-made by Sigma. PCR master mix (2· ;
Fermentas) and nuclease-free water (Fermentas) were used.
For each round of reaction, a no-template control was in-
cluded. PCR products were analyzed using 4% (w/v) aga-
rose E-gels (Invitrogen) together with an E-gel PowerBase
system (Invitrogen). The sizes of PCR products were iden-
tified by running a Quick-Load PCR marker (Biolabs) in
parallel. Images were taken by exposing the gels under UV
light in a Kodak Gel Logic 1500 system (Eastman Kodak).
Biochemical assays
Biochemical assays were performed on fresh (n = 6) and
decellularized (n= 6) porcine pulmonary leaflets and pul-
monary artery wall samples, which had been lyophilized to
constant weight.
Hydroxyproline assay. Samples were hydrolyzed in 6M
hydrochloric acid for 6 h at 120C, at 15 lb.sqin- 1 and neu-
tralized with 6M sodium hydroxide. The hydroxyproline
assay was performed as described by Edwards and O’Brien.23
The hydroxyproline content was determined by interpolation
from a trans-4-hydroxy-L-proline standard curve.
Denatured collagen assay. The assay was performed as
described by Bank et al.24 Samples were treated with
5mg.mL - 1 a-chymotrypsin (Sigma) in 0.1M tris buffer
containing 2.5mM calcium chloride for 24 h at 30C. The
samples were centrifuged at 600 g for 10min. The super-
natant was hydrolyzed, neutralized, and the hydroxyproline
content was determined as described above.
GAG assay. Samples were digested by incubating with
5mL of 50U.mL - 1 papain (Sigma-Aldrich) solution for
48 h at 60C. The diluted tissue digestion solution (40mL)
was mixed with 250mL DMB dye solution (1.6% [w/v] 1,9
dimethylene blue [Sigma-Aldrich], 0.5% [v/v] ethanol
[VWR International], 0.2% [v/v] formic acid [Sigma-
Aldrich], 0.2% [w/v] sodium formate [VWR International],
pH 3.0), and the optical densities were measured using a
microplate spectrophotometer at 525 nm. The GAG content
was determined by interpolation from a chondroitin sulphate
B (Sigma-Aldrich) standard curve.
Determination of the presence of xenoantigen a-gal
Zinc fixed tissue sections (10 mm) were labeled with anti
galactose-a-1,3-galactose (a-gal; Alexis Biochemicals) at a
concentration of 1mg.mL - 1 using the Ultravision Detection
system. An antigen unmask solution (Vector) was used for
antigen retrieval, and hydrogen peroxide (Sigma) was used
to block endogenous peroxidase. Porcine artery served as
the positive control tissue. An IgM isotype control and the
absence of primary antibody were used as negative controls.
An antibody absorption assay was employed on fresh, de-
cellularized, and a-galactosidase-treated tissue to quantitate
the a-gal. Tissue samples (100mg; n = 6) were analyzed as
described by Stapleton et al.25
Biomechanical assessment
Uniaxial tensile loading to failure. Leaflet specimens
measuring 6 · 3mm (circumferential and radial directions;
minimum six per group), and circumferential or axial wall
specimens measuring 10 · 5mm (minimum six per group)
were isolated and their thickness was measured using a
Mitutoyo thickness gauge. The specimens were then
mounted at a relaxed state onto a purpose-built clamping
holder, which was then mounted into a Shimazu tensile
testing machine. The samples were preloaded to 0.02N and
were then loaded to failure at a speed of 10mm per minute.
Failure was taken as the first decrease in the recorded load
during extension. The real-time load and extension data
were recorded during tests. The stress–strain behavior of the
specimens was analyzed in terms of the elastin phase slope,
collagen phase slope, transition stress, transition strain,
failure stress, and the failure strain as described by Korossis
et al.26
Pulsatile flow testing. The pulmonary root hydrodynam-
ics was evaluated using near physiological pulsatile flow
testing. The flow simulator has been described previously.27
It mimicked the right heart and was controlled and monitored
by the ViviTest software (Vivitro Systems, Inc.). The simu-
lator was set up as described by Korossis et al.28 Fresh and
decellularized porcine pulmonary roots (n= 6) were tested
under three different pulsatile flow conditions (Table 1). The
pressures applied under each condition were the minimum
pressures that could be achieved by the simulator at the re-
quired cardiac output. The hydrodynamic performance of the
pulmonary roots was assessed by mean pressure drop across
the valves (Dp), the root mean square (RMS) forward flow,
and the valve effective orifice area (EOA), which was cal-
culated according to the experimental formula:29
EOA¼ QRMS
51:6 ·Dp
The leaflet kinematics was assessed during a complete
cardiac cycle under pulsatile flow condition 2 (Table 1). The
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leaflet motion was recorded using a high speed camera
(Redlake Motion Scope, Model PCI 1000S) at a recording
rate of 250 frames per second. The phase durations were
determined by counting the number of video frames be-
tween the reference points (start opening, fully open, start
closing, fully closed, and start opening) and multiplying it
by the frame acquisition interval (4ms).
In vitro biocompatibility assays
Cell culture. 3T3 murine fibroblasts (ECACC) were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% (v/v) FBS, 100U.mL - 1 penicillin,
100 mg.mL - 1 streptomycin, and 100mM L-glutamine
(Lonza) at 37C in 5% CO2 (v/v) in air.
BHK baby hamster kidney cells (ECACC) were cultured
in Glasgow’s modified Eagle’s medium (GMEM) con-
taining 5% (v/v) FBS, 10% (v/v) tryptose phosphate broth
(Oxoid) at 37C in 100U.mL - 1 penicillin, 100 mg.mL - 1
streptomycin, and 100mM L-glutamine, 5% CO2 (v/v)
in air.
Contact cytotoxicity assay. Decellularized porcine pul-
monary leaflet samples (5mm2, n = 6) were attached to the
center of the wells of a six-well culture plate using collagen
gel extracted from rat tail tendons. Decellularized pulmo-
nary artery samples (5mm2, n = 6) were attached to the
center of the wells using steri strips. Cyanoacrylate glue was
used as positive control, and collagen gel or steri strips alone
were used as the negative control. 3T3 or BHK cells were
seeded into each well at a density that allowed 80% con-
fluence after cell seeding. Plates were incubated at 37C in
5% (v/v) CO2 in air for 48 h. The cells were fixed with 10%
(v/v) NBF for 10min prior to staining with Giemsa solution
(VWR International) for 5min. The culture wells were
carefully rinsed with distilled water until water ran clear and
air-dried before being examined under a brightfield micro-
scope for cell morphology and distribution.
Extract cytotoxicity assay. Decellularized porcine pul-
monary artery samples (n = 6) were finely minced, weighed,
and incubated in DMEM or GMEM (1mL medium per
100mg tissue) in sterile Eppendorf tubes for 72 h with ag-
itation. Following incubation, the extracts were centrifuged
at 15,000 g for 15min and the supernatant was collected.
Cells (3T3 and BHK) were seeded into a 96-well plate at
10,000 cells per well, and incubated overnight at 37C in
5% (v/v) CO2 in air. The cell culture medium was removed
and 100mL of fresh culture medium and 100 mL of the tissue
extract were added to each well. The cells were incubated
with 200mL of 40% (v/v) dimethyl sulfoxide (DMSO;
Sigma Aldrich) in DMEM or GMEM as positive controls.
The negative control consisted of 200mL cell culture me-
dium alone. The cells were incubated at 37C in 5% (v/v)
CO2 in air for 24 h. The cell viability [relative cellular
adenosine triphosphate (ATP) content] was determined us-
ing the ATP Lite-M assay (Packard) as per the manufac-
turer’s instruction. Data were recorded as luminescent
counts per second.
Table 1. Flow Conditions Used
in the Hydrodynamic Testing
Condition
Heart
rate
(bpm)
Stroke
volume
(mL)
Cardiac
output
(l.min - 1)
Pulmonary
pressure
(mmHg)
1 60 60 3.60 35/5
2 72 70 5.04 45/10
3 80 70 5.60 50/10
FIG. 1. Histological and immunohistochemical images of fresh porcine pulmonary leaflets and pulmonary arteries. (A)
Fresh pulmonary leaflet stained with Masson’s trichrome, 100· ; (B) Fresh pulmonary artery stained with hematoxylin and
eosin (H&E), 100· ; (C) Fresh connection stained with Masson’s trichrome, 50· ; (D) Fresh pulmonary artery stained for
fibronectin, 100· ; (E) Fresh pulmonary artery stained for collagen type IV, 100· ; (F) Transmission electron micrograph of
fresh pulmonary leaflet, 1500· . Color images available online at www.liebertpub.com/tea
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Data analysis
All numerical data were analyzed using Microsoft Excel
(Version 2003 or 2007), and all data were presented as
mean – 95% confidence intervals (CI). The Student’s t-test
was used for comparison of two group means. One-way
ANOVA followed by calculation of the minimum signifi-
cance difference (MSD) by the T-method at the 95% CI,
was used to analyze data from more than two groups. In-
dividual differences between group means were identified
by comparing the difference between two group means to
the MSD.30
Results
Histological analysis
Histological analysis of the native porcine root using a
range of staining techniques revealed the cellular distribu-
tion in the tissue and characteristic tri-laminar structure of
the pulmonary valve leaflets, the structure of the leaflet
connection, and collagen arrangement in the pulmonary
artery wall. Representative images are shown in Figure 1A–
C. The connection is the region where the root of the
pulmonary leaflet attaches to the myocardium and the pul-
monary artery and both leaflet tissue and myocardium tissue
were recognizable in the image of the connection area
(Fig. 1C). Cells throughout the fresh porcine pulmonary root
were positive for vimentin (data not shown) and the arterial
matrix was rich in fibronectin (Fig. 1D). The endothelial
layer was positive for vWF (data not shown). Collagen type
IV staining was found in the region of the basement mem-
brane (Fig. 1E). There was no evidence of cells throughout
the acellular pulmonary root, whereas the tissue histoarch-
itecture was well preserved following decellularization (Fig.
2A–C). Hoechst staining was negative in the acellular tissue
(data not shown). Staining for vimentin, vWF, and collagen
type IV was negative in acellular tissue samples (Fig. 2E)
and acellular pulmonary artery was less intensely stained for
fibronectin (Fig. 2D), particularly in regions close to the
surface compared to the fresh tissue (Fig. 1D). No obvious
difference in the collagen fiber distribution between the
fresh and acellular leaflets was observed by transmission
electron microscopy (TEM) (Figs. 1F and 2F).
DNA content
Total DNA content was reduced to less than 100 ng.mg- 1
tissue dry weight in all regions of the acellular porcine
pulmonary root (Table 2). The DNA content of the acellular
tissue was less than 4% of the DNA content of fresh tissue in
all regions.
Polymerase chain reaction
GAPDH, SLA-2, b2 microglobulin, and b-actin gene
fragments were positively amplified from fresh tissue DNA
template, whereas no PCR product was detected in the
acellular samples or the blank reactions (Fig. 3).
FIG. 2. Histological and immunohistochemical images of acellular porcine pulmonary leaflets and pulmonary arteries.
(A) Acellular pulmonary leaflet stained with picrosirius red/Miller’s elastin, 100· ; (B) Acellular pulmonary artery stained
with H&E; (C) Acellular connection stained with Masson’s trichrome, 50 · ; (D) Acellular pulmonary artery stained for
fibronectin, 100· ; (E) Acellular pulmonary artery stained for collagen type IV, 100· ; (F) Transmission electron micro-
graph of acellular pulmonary leaflet, 1500· . Color images available online at www.liebertpub.com/tea
Table 2. DNA Content of Fresh and Acellular Porcine Pulmonary Roots
Leaflets Wall Myocardium Connection
Fresh (ng.mg - 1) 7190 – 210 4060– 710 4290 – 620 2840 – 850
Acellular (ng.mg - 1) 60.7 – 20.0 36.5 – 9.1 53.6 – 13.9 95.7 – 15.9
Data are expressed as the mean (n = 6)– 95% confidence limits. p < 0.05 for all acellular versus fresh.
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Biochemical assays
The biochemical assay results are presented in Table 3.
The relative hydroxyproline content in the tissue was sig-
nificantly elevated after decellularization ( p < 0.05). No
significant difference was found between fresh and acellular
pulmonary leaflet denatured collagen content ( p > 0.05).
However, a small but significantly higher level of denatured
collagen was revealed in the pulmonary artery following
decellularization ( p < 0.05). Moreover, there was a signifi-
cant reduction in the GAG content of the acellular tissue
compared with the fresh ( p< 0.05).
Determination of the presence of xenoantigen a-gal
Fresh pulmonary leaflets and arteries were positive for a-
gal (Fig. 4A, C). The a-gal was mainly distributed on the
endothelial layer and spongiosa layer in the fresh pulmonary
leaflets (Fig. 4A). No evidence of positive staining was
observed throughout the acellular porcine pulmonary roots
(Fig. 4B, D).
Fresh porcine pulmonary arteries absorbed anti a-gal
antibodies. Treatment of the tissue with a-galactosidase
abrogated antibody binding. The levels of anti a-gal anti-
bodies absorbed by the acellular tissue were not significantly
different from the a-galactosidase-treated fresh tissue or no
tissue control indicating that the acellular pulmonary arteries
did not contain a-gal, and they were comparable to the
tissue from which the a-gal had been enzymatically re-
moved (Fig. 5).
Biomechanical assessment
Uniaxial tensile loading to failure. A representative mean
stress–strain behavior curve for the fresh and acellular pul-
monary wall in the circumferential direction is shown in
Figure 6. There was no significant difference in the tensile
properties between acellular and fresh pulmonary leaflets.
Fresh and acellular pulmonary arteries also showed no sig-
nificant difference in their tensile properties, with the ex-
ception of a significant increase ( p < 0.05) in the elastin
phase slope of the acellular pulmonary artery in both di-
rections (Table 4).
Hydrodynamic assessment. The fresh and acellular
groups demonstrated similar hydrodynamic performance
under all three test conditions listed in Table 1 as shown in
FIG. 3. PCR products on a 4% E gel for GAPDH (A), SLA-2 (B), b 2-microglobulin (C), and b-actin (D). Lane 1: Quick-
Load PCR marker (Biolabs); Lane 2–5: fresh porcine pulmonary leaflet, fresh porcine pulmonary artery, fresh porcine
myocardium, fresh porcine pulmonary leaflet connection; a band is present on the gel at around 600 bp (A), 250 bp (B),
760 bp (C), and 300 bp (D). Lane 6–9: acellular porcine pulmonary leaflet, acellular porcine pulmonary artery, acellular
porcine myocardium, acellular porcine pulmonary leaflet connection; no band is present on the gel. Lane 10: blank; no band
is present on the gel.
Table 3. Biochemical Characterization of Fresh and Acellular Porcine Pulmonary Roots
Assay
Fresh leaflets
(lg.mg - 1)
Acellular leaflets
(lg.mg- 1)
Fresh wall
(lg.mg- 1)
Acellular wall
(lg.mg- 1)
Hydroxyproline 70.7 – 6.2 133.8 – 17.5a 36.3 – 3.0 54.3– 3.0a
Denatured collagen 3.5 – 0.6 2.8 – 0.7 2.8 – 0.3 4.5 – 0.3a
GAG 20.2 – 0.6 4.0 – 0.4a 9.7 – 1.2 4.3 – 0.8a
Data are expressed as the mean (n = 6) – 95% confidence limits.
aIndicates p < 0.05 acellular versus fresh.
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Figure 7A. There was no significant difference of the av-
erage EOA (Fig. 7B) between fresh and decellularized
groups in any of the test conditions used ( p > 0.05).
Leaflet kinematics. Both fresh and decellularized valves
demonstrated synchronous opening and closing leaflet mo-
tion (Fig. 8A). During opening, all fresh and decellularized
roots demonstrated the same stellate, triangular, and circular
configurations as previously described for the semilunar
valves.31,32 All valves demonstrated fully closed leaflet
configurations with no visible leakage orifices or coaptation
flaws during diastole. The decellularized valve leaflets were
more transparent than the fresh leaflets. The durations of the
opening, open, closing, and closed phases averaged over the
number of roots studied are shown in Figure 8. The opening
phase duration of the decellularized group was considerably
longer than that of the fresh roots, and the mean of the
closed phase duration of the decellularized roots was much
shorter than that of the fresh roots. However, no statistically
significant difference was observed between the fresh and
decellularized groups in any of the phases studied.
In vitro biocompatibility assays
Contact cytotoxicity assay. Microscopic images showed
that 3T3 cells (Fig. 9) and BHK cells (data not shown) grew
up to and in contact with the acellular pulmonary leaflets
and artery wall tissue with no change in morphology com-
pared to the controls. Collagen or steri strip alone (negative
controls) showed no signs of cytotoxicity (data not shown).
When cultured with cyanoacrylate glue, no evidence of cells
was found in a circular area around the adhesive (data not
shown).
FIG. 4. Localization of a-gal in
fresh and acellular porcine pulmonary
leaflets and arteries. (A) Fresh pul-
monary leaflet; (B) Acellular pulmo-
nary valve leaflet; (C) Fresh
pulmonary artery; (D) Acellular pul-
monary artery. All images were 100 ·
magnification. Color images available
online at www.liebertpub.com/tea
FIG. 5. Antibody absorption assay for a-gal. Data show
the remaining anti a-gal antibodies following absorption
with fresh, acellular, and galactosidase-treated acellular
pulmonary arteries. NTC: no tissue control. Data are re-
presented as the mean (n = 6) – 96% CI. Data were analyzed
using one-way ANOVA followed by calculation of the MSD
by the T-method ( p< 0.05). There were no significant dif-
ferences except when comparing the fresh tissue with all of
the other groups.
FIG. 6. Mean stress–strain behavior for the fresh (n = 6)
and acellular (n = 6) circumferential pulmonary wall groups.
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Extract cytotoxicity assay. ATP levels were significantly
lower in the positive control ( p < 0.05) compared with the
negative control for both 3T3 and BHK cells (Fig. 10). The
mean ATP content of the cells cultured with the six acellular
porcine pulmonary artery extracts were not significantly
different from the negative control for both cell types. When
comparing the ATP level of cells cultured with individual
decellularized pulmonary roots to the negative control, a
significant increase in ATP level was observed in one out of
six acellular pulmonary artery extracts cultured with both
cell types.
Discussion
Decellularization was performed through modification of a
previously developed method for porcine aortic valve con-
duit.21 The process utilized 1.25% (w/v) trypsin digestion of
the adventitial surface of the scraped pulmonary artery,
washing in 0.1% (w/v) SDS-hypotonic buffer in the presence
of proteinase inhibitors and two cycles of nuclease treatment.
Extensive PBS washes after each step and at the end of
process were applied to wash out cell remnants and chemical
residuals. The method was developed with care to cause
minimal damage to the extracellular matrix (ECM) and pro-
duced biocompatible acellular porcine pulmonary roots that
were devoid of cells and the a-gal epitope, and minimal ef-
fects on the biomechanical and hydrodynamic function of the
valves. The decellularization approach described in this study
was suitable for pulmonary root conduits in the size 20–
24mm. Modifications to the process may be required for
conduits of smaller size from younger pigs.
There was no evidence of cells in the acellular tissue, as
determined by histology and Hoescht, vWF, and vimentin
staining, whereas the histoarchitecture of the ECM was not
affected by the process. TEM analysis of the leaflet tissues
showed no obvious sign of damage to the collagen fibers.
The levels of fibronectin were reduced, particularly near the
surface of the acellular tissues compared with fresh tissue
indicating partial removal during the wash cycles. Collagen
type IV was used as a marker for the basement membrane,
which is believed to be important for endothelialization.33
The acellular pulmonary roots were devoid of collagen type
IV staining, which was in contrast to studies reported by
others for SDS-decellularized porcine pulmonary valve.34
Recent data within our group have suggested that the PAA
treatment, and not the SDS treatment, abrogates collagen IV
staining in decellularized porcine arteries (unpublished
data). The PAA treatment could have removed collagen IV
from the tissue or altered the collagen IV molecule such that
the epitope recognized by the anti-collagen IV antibody was
Table 4. Elastin (EL-E) and Collagen (COL-E) Phase Slopes, Ultimate Tensile Strength (eUTS),
and Failure Strain (eUTS) Following Uniaxial Tensile Testing of Fresh and Acellular Porcine Pulmonary
Leaflets (Circumferential and Radial Directions) and Arteries (Circumferential and Axial Directions)
Assay EL-E (kPa) Coll-E (MPa) rUTS (MPa) eUTS (%)
Fresh leaflet (C) 755– 286 15.3 – 3.6 5.27 – 1.59 58.2 – 14.3
Acellular leaflet (C) 763– 219 21.5 – 9.3 5.96 – 1.55 59.4 – 11.5
Fresh leaflet (R) 342– 62 1.19 – 0.24 0.51 – 0.10 67.2 – 14.2
Acellular leaflet (R) 352– 56 1.29 – 0.27 0.64 – 0.05 60.6 – 14.8
Fresh wall (C) 44– 5 0.79 – 0.23 0.590.08 208.8– 24.4
Acellular wall (C) 55– 4a 0.85 – 0.12 0.56 – 0.08 177.0– 17.9
Fresh wall (A) 31– 4 0.51 – 0.10 0.42 – 0.04 209.7– 25.4
Acellular wall (A) 52– 8a 0.46 – 0.10 0.37 – 0.04 180.0– 12.0
Data are expressed as the mean (n = 6) – 95% confidence limits. Data were analyzed by ANOVA, which revealed significant difference in
elastin slope between fresh and decellularized tissue (a).
C, circumferential direction; R, radial direction; A, axial direction.
FIG. 7. Hydrodynamic assessment of fresh and acellular
pulmonary roots. (A) Average Dp versus average RMS flow
for the fresh (n = 6) and acellular (n = 6) groups at the three
test conditions (Table 1). (B) Average EOA for the fresh
(n = 6) and acellular (n = 6) porcine pulmonary roots at each
test conditions (Table 1). The error bars indicate the 95%
confidence intervals (CIs). No significant differences were
found between the two groups.
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no longer available for binding. Whether this has an effect
on the endothelialization of the roots will have to be re-
vealed by further studies.
Determination of the DNA content of acellular biological
scaffolds is considered to be important in determining the
success of a decellularization protocol.35–37 Previous studies
have shown that residual DNA is present in experimental and
commercially available acellular biological scaffolds.38–40
Short lengths of DNA (less than 300 bp) are not considered to
be of concern.38,41–43 Greater than 96% DNA removal was
achieved for all regions with residual levels of less than
100 ng per mg dry weight. A limitation of the methods used
was that for the acellular tissue the readings in the Nanodrop
spectrophotometer were at the lowest end of sensitivity of
2 ng.mL - 1. Thus, it was likely that the amount of residual
DNA was in fact lower than it was actually found. It should
be noted that, in the majority of studies of this nature, the
Picogreen assay is used to detect double-stranded DNA38
and not total DNA as reported here. PCR was used to deter-
mine target gene expression in the extracted DNA. House-
keeping genes were selected because they are universal in
cell DNA. No PCR product was identified in any of the
DNA samples extracted from the acellular tissues, providing
further evidence of the removal of cellular DNA from the
acellular tissue.
The a-gal epitope is the major xenoantigen causing hy-
peracute rejection and a-gal expressed by residual cells was
reported to be the most likely reason for the failure of Sy-
nergraft (Cryolife) acellular xenograft heart valve.16 No
evidence of residual a-gal was identified in the acellular
pulmonary valves by immunohistochemical staining or a
previously adopted a-gal absorption assay.
The hydroxyproline levels (representative of collagen) as
a proportion of the mass of tissue were significantly higher
FIG. 8. Leaflet kinematics of
fresh and acellular pulmonary
roots. (A) Sequence of video
images showing the deforma-
tion a representative fresh (I, II,
III, IV) and acellular (V, VI,
VII, VIII) left pulmonary leaf-
let (leaflet a) at start opening (I,
V), fully open (II, VI), start
closing (III, VII), and fully
closed (IV, VIII) positions. (B)
Phase times for the fresh (n = 6)
and acellular (n = 6) pulmonary
roots at test Condition 2. The
error bars indicate the 95% CIs.
No significant differences were
found between the two groups.
FIG. 9. Contact cytotoxicity assays
of acellular porcine pulmonary leaflets
and arteries following 48 h culture
with murine 3T3 fibroblasts. (A) Pul-
monary leaflet adhered with collagen
gel, 100 · ; (B) Pulmonary artery ad-
hered with steri strips, 100 · . Color
images available online at www
.liebertpub.com/tea
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in the acellular pulmonary leaflet and artery than in the fresh
tissue. The most likely reason was due to the loss of cell
mass following decellularization. There was significant in-
crease in the denatured collagen content of the arterial wall
tissue, but not in the leaflet tissue following decellulariza-
tion, which was most likely due to the trypsin treatment
applied to the wall to aid the diffusion of the decellular-
ization solutions. A significant reduction in the GAG level
was observed in the pulmonary leaflet and pulmonary ar-
teries following decellularization. Similar findings of GAG
loss have been reported for different types of tissues de-
cellularized using SDS.44,45 Since GAG is the major com-
ponent in the spongiosa of the pulmonary leaflets it was
important to examine the effect of GAG loss on the hy-
drodynamic function of the acellular valves.
There was no significant difference in the tensile prop-
erties of the acellular tissue compared with fresh except for
a significant decrease in the elastin phase slope in both the
circumferential and axial directions of the acellular arterial
wall. Similar changes have been described by Korossis
et al.28 for porcine aortic conduits. This indicated that de-
cellularization produced a more compliant tissue in the
initial elastin phase (physiological range). The fact that no
changes in the collagen phase slope, ultimate stress, or
failure strain were demonstrated indicated that the small
increase in denatured collagen in the arterial wall did not
affect the strength of the acellular pulmonary root. The
hydrodynamic performance and leaflet kinematics of the
acellular pulmonary roots were similar to the fresh valves.
The hydrodynamic performance of the fresh porcine pul-
monary roots was compared to the pulmonary homograft
(the current gold standard)46 and the fresh porcine pulmo-
nary roots tested by others47 under similar conditions. The
pressure drops generated by the fresh pulmonary roots in
this study complied to previous studies.46,47 The hydrody-
namic performance of the acellular roots was similar to the
fresh roots. No significant difference was observed for either
EOA or leaflet phase durations between the decellularized
and fresh pulmonary roots, in any of the flow conditions
used. These results demonstrated that the decellularization
process and reduction in GAG levels in the acellular valves
did not adversely affect the functional performance of the
acellular pulmonary roots.
Currently available acellular xenogeneic pulmonary heart
valve scaffolds have shown clinical outcomes 17–20 that have
indicated the need for the development of acellular valved
conduits that are devoid of cells, DNA and residual a-gal.
To the authors’ knowledge, this is the first study that has
assessed the total DNA and the presence of a-gal in all
regions (leaflets, pulmonary wall, myocardium, and leaflet
connection) of an acellular porcine pulmonary root conduit.
The absence of functional housekeeping genes in the acel-
lular conduit also provided further evidence of the removal
of cellular DNA. Furthermore, the biomechanical and hy-
drodynamic properties of the conduit indicated that this
level of cell and antigen removal was achieved without
compromising the biomechanical attributes of conduit.
In conclusion, the acellular porcine pulmonary roots
have excellent potential for development as valve substi-
tutes for RVOT reconstruction e.g., during the Ross pro-
cedure. The regenerative potential of the acellular conduits
will be assessed in future studies, in a suitable large animal
model.
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